Carotid Plaque Rupture Is Accompanied by an Increase in the Ratio of Serum circR-284 to miR-221 Levels.
Carotid Plaque Rupture Is Accompanied by an Increase in the Ratio of Serum circR-284 to miR-221 Levels.
复制标题
DOI:
10.1161/circgenetics.117.001720
复制
发表时间:
2017-08
期刊:
影响因子:
--
通讯作者:
Woods TC
中科院分区:
文献类型:
--
作者:
Bazan HA;Hatfield SA;Brug A;Brooks AJ;Lightell DJ Jr;Woods TC
Atherosclerotic plaque rupture is accompanied by an acute decrease in the carotid plaque expression of microRNAs (miRs) -221 and -222. Circular RNA (circR)-284 is a potential inhibitor of miR-221/-222 activity. We aimed to determine whether changes in the serum levels of these non-coding RNAs (ncRNAs) are observed in patients with asymptomatic high-grade carotid disease versus patients with acutely symptomatic carotid disease and recent ischemic stroke. Additionally, we tested the use of functionally related ncRNA pairs to enhance the discriminatory power of ncRNAs as circulating biomarkers. Serum levels of miR -221,-222, -145 and circR-284 were measured in 24 asymptomatic (Asymptomatic) and 17 acutely symptomatic patients ([Urgent] ischemic cerebrovascular event within the previous 5 days) undergoing carotid endarterectomy (CEA). miR-221 was significantly lower while circR-284 was elevated in the serum of the Urgent compared to the Asymptomatic group. The ratio of serum circR-284:miR-221, was significantly elevated in the Urgent group (p = 0.0002) and exhibited favorable characteristics as a biomarker indicative of carotid plaque rupture and stroke. A validation study in 112 patients (47 Asymptomatic, 41 Urgent, and 24 patients with a cerebrovascular event between 5 to 180 days of the CEA [Symptomatic]) confirmed elevation of serum circR-284:miR-221 uniquely in the Urgent group (p < 0.001) and favorable sensitivity and specificity for detecting plaque rupture and stroke. Serum circR-284:miR-221 has potential as a diagnostic biomarker of carotid plaque rupture and stroke. Moreover, we demonstrate use of functionally related pairs of circulating ncRNAs as biomarkers in cardiovascular disease.